Balthaser Kevin
CIK 0001957554
Chief Financial Officer
Filings
16
Latest Mar 3, 2026
Issuers covered
1
Showing
16 of 16
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 67% | +14.8% | +31.6% | +32.5% | -19.7% |
| 90 days | 3 | 67% | -7.1% | +31.9% | +33.8% | -86.9% |
| 180 days | 3 | 67% | -0.8% | +39.9% | +41.3% | -83.4% |
| 365 days | 3 | 67% | +32.0% | +90.2% | +90.2% | -84.4% |
Issuers
Companies where Balthaser Kevin has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | 16 | Mar 3, 2026 |
All filings
16 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|